By sequencing the integrations of B ALL samples, recurrent truncating mutations were observed in Ebf1, a tumor suppressor of B ALL (75, 76) which encodes a transcriptional activator of another B cell ALL tumor suppressor Pax5. Here, EBF1 is linked to neoplasm.